Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-29 Purchase | 2024-01-31 4:26 pm | Tourmaline Bio Inc. | TRML | MCDADE MARK Director | 100,000 | $32.5 | $3,250,000 | 742,209 (Indirect Direct) | View |
| 2023-01-27 Purchase | 2023-04-11 7:55 pm | Jasper Therapeutics Inc. | JSPR | Qiming U.S. Healthcare Fund II L.P. Qiming U.S. Healthcare GP II LLC MCDADE MARK RIESCHEL GARY E 10% Owner | 2,666,666 | $1.5 | $3,999,999 | 8,519,648 (Direct) | View |
| 2022-04-01 Purchase | 2022-04-05 4:10 pm | Icosavax Inc. | ICVX | MCDADE MARK Director | 42,225 | $7.1 | $299,798 | 3,560,471 (Indirect Direct) | View |
| 2021-08-02 Purchase | 2021-08-02 9:27 pm | Icosavax Inc. | ICVX | Qiming U.S. Healthcare Fund II L.P. Qiming U.S. Healthcare GP II LLC MCDADE MARK Former 10% Owner | 221,351 | $15 | $3,320,265 | 3,523,561 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-05 Option Award | 2024-06-07 4:03 pm | N/A 2034-06-04 | Tourmaline Bio Inc. | TRML | MCDADE MARK Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-02-19 Disposition | 2024-02-20 7:38 pm | N/A N/A | Icosavax Inc. | ICVX | MCDADE MARK See Remarks | 39,278 | $0 | 0 (Direct) | View |
| 2024-02-19 Equity Swap | 2024-02-20 7:38 pm | N/A N/A | Icosavax Inc. | ICVX | MCDADE MARK See Remarks | 3,566,014 | $0 | 0 (Direct) | View |
| 2023-10-19 Disposition | 2023-10-23 8:26 pm | N/A 2033-06-13 | Tourmaline Bio Inc. | TRML | MCDADE MARK Director | 20,500 | $0 | 662,209 (Direct) | View |
| 2023-10-23 Option Award | 2023-10-23 8:26 pm | N/A 2033-10-22 | Tourmaline Bio Inc. | TRML | MCDADE MARK Director | 368,949 | $0 | 662,209 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-14 6:59 pm | N/A 2033-06-13 | Talaris Therapeutics Inc. | TALS | MCDADE MARK Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 8:46 pm | N/A 2033-06-05 | Icosavax Inc. | ICVX | MCDADE MARK Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 4:12 pm | N/A 2032-06-09 | Icosavax Inc. | ICVX | MCDADE MARK Director | 27,821 | $0 | 3,588,292 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 6:20 pm | N/A 2032-06-08 | Talaris Therapeutics Inc. | TALS | MCDADE MARK Director | 14,501 | $0 | 14,501 (Direct) | View |
Ownership | 2021-10-01 4:08 pm | N/A N/A | Jasper Therapeutics Inc. | JSPR | Qiming U.S. Healthcare Fund II L.P. Qiming U.S. Healthcare GP II LLC MCDADE MARK 10% Owner | 0 | $0 | 5,852,982 (Direct) | View |
| 2021-08-02 Conversion | 2021-08-02 9:27 pm | N/A N/A | Icosavax Inc. | ICVX | Qiming U.S. Healthcare Fund II L.P. Qiming U.S. Healthcare GP II LLC MCDADE MARK Former 10% Owner | 17,066,543 | $0 | 3,523,561 (Direct) | View |
Ownership | 2021-07-28 9:17 pm | N/A N/A | Icosavax Inc. | ICVX | Qiming U.S. Healthcare Fund II L.P. Qiming U.S. Healthcare GP II LLC MCDADE MARK Director 10% Owner | 0 | $0 | 3,310,228 (Direct) | View |
| 2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | MCDADE MARK Director | 19,755 | $19.1 | 0 (Direct) | View |
| 2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | MCDADE MARK Director | 15,398 | $17.39 | 0 (Direct) | View |
| 2020-10-10 Equity Swap | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | MCDADE MARK Director | 26,852 | $34.5 | 0 (Direct) | View |
| 2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | MCDADE MARK Director | 104,842 | $31.48 | 0 (Direct) | View |
| 2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | MCDADE MARK Director | 7,840 | $34.5 | 0 (Direct) | View |
| 2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | MCDADE MARK Director | 17,500 | $16.24 | 0 (Direct) | View |
| 2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | MCDADE MARK Director | 11,432 | $14.6 | 0 (Direct) | View |
| 2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | MCDADE MARK Director | 7,500 | $1.71 | 0 (Direct) | View |
| 2020-05-27 Option Award | 2020-05-29 7:13 pm | N/A 2030-05-26 | Aimmune Therapeutics Inc. | AIMT | MCDADE MARK Director | 23,238 | $0 | 50,090 (Direct) | View |
| 2020-02-20 Disposition | 2020-02-24 7:33 pm | N/A N/A | Dermira Inc. | DERM | MCDADE MARK Director | 6,000 | $18.75 | 0 (Direct) | View |
| 2020-02-20 Disposition | 2020-02-24 7:33 pm | N/A 2024-10-01 | Dermira Inc. | DERM | MCDADE MARK Director | 62,377 | $0 | 0 (Direct) | View |